Top compounds associated with response to OR2L5


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA PIK-93 CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.11 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.11 0.002
Download CSV